Muscle atrophy prevention agent
AssigneeMegmilk Snow Brand Co., Ltd.
InventorsKen UKIBE, Daisuke KAWATA, Yasuyuki SETO
Life of this patent
Estimating the term…
Abstract
An object of the invention is to provide a novel technique for preventing muscle atrophy by directly promoting muscle synthesis or suppressing muscle degradation without through physical activity. An agent for preventing muscle atrophy containing a lactic acid bacterium having a muscle synthesis-promoting effect and/or a muscle degradation-suppressing effect, a treated product of the lactic acid bacterium or an extract thereof as an active ingredient in which the lactic acid bacterium having a muscle synthesis-promoting effect is Lactobacillus gasseri or the like and the lactic acid bacterium having a muscle degradation-suppressing effect is Lactobacillus reuteri or the like is provided.
Claims10
An agent for preventing muscle atrophy comprising a lactic acid bacterium having a muscle synthesis-promoting effect and/or a muscle degradation-suppressing effect, a treated product of the lactic acid bacterium or an extract thereof as an active ingredient,
- wherein the lactic acid bacterium having a muscle synthesis-promoting effect is any one kind or more selected from the group consisting of Lactobacillus gasseri, Streptococcus thermophilus, Lactobacillus rhamnosus, Lactococcus lactis, Lactobacillus delbrueckii and Lactobacillus reuteri, and
- the lactic acid bacterium having a muscle degradation-suppressing effect is any one kind or more selected from the group consisting of Lactobacillus reuteri, Lactobacillus mucosae, Lactobacillus fermentum, Pediococcus acidilactici, Lactobacillus delbrueckii and Lactobacillus gasseri.
An agent for preventing muscle atrophy comprising a lactic acid bacterium having a muscle synthesis-promoting effect and a muscle degradation-suppressing effect, a treated product of the lactic acid bacterium or an extract thereof as an active ingredient.
Lactobacillus delbrueckii subsp. lactis strain SBT1371 (NITE BP-03277), Lactobacillus delbrueckii subsp. lactis strain SBT2002 (NITE BP-03280), Lactobacillus delbrueckii subsp. lactis strain SBT2080 (NITE BP-03281), Lactococcus lactis subsp. cremoris strain SBT1393 (NITE P-03278), Lactobacillus reuteri strain SBT2970 (NITE BP-03282), Lactobacillus mucosae strain SBT10038 (NITE P-03283) and Lactobacillus fermentum strain SBT1846 (NITE P-03279) which are novel lactic acid bacteria.
Dependencies are inferred from the claim text.